Pharmafile Logo
Pharmafocus logo
Advanced Search
amgen_hq

FDA and NICE approve of first new hyperparathyroidism drug in 12 years

March 8, 2017
Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …

News
web_scientist-filling-out-form---credit-national-institutes-of-health

Diabetes drug could be key to treating aggressive breast cancer, research suggests

March 8, 2017
Research and Development Cancer, diabetes

Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …

News
child

Research gives hope of potential treatment for most deadly paediatric brain tumour

March 8, 2017
Research and Development

A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …

News
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017
Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …

News
shutterstock_38078521

Researchers discover worrying new antibiotic-resistance gene variant

March 7, 2017
Manufacturing and Production, Research and Development drug resistance

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …

News
shutterstock_92671375

Cadila and Supernus settle patent dispute over epilepsy generic

March 7, 2017
Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …

News

Merck’s Allergopharma opens €42m biopharmaceutical plant

March 7, 2017
Manufacturing and Production Allergopharma, Merck

Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …

News
bernie_2

Vermont senators call for restraints on “beautiful” pharma advertising

March 6, 2017
Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing

Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …

News
sink

FDA approves first treatment for excessive night-time urination

March 6, 2017
Manufacturing and Production FDA, Noctiva, Serenity

The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – …

News
europe_tied_in_knots

Negotiating the EU pricing system: How the financial crisis has encouraged closer-knit cooperation between member states

March 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, pricing

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …

Feature

Lilly posts impressive psoriasis results in comparison study

March 6, 2017
Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …

News
mediaphoto7_large

Cipla halts HIV drug production due to delayed government funding

March 6, 2017
Sales and Marketing Cipla, HIV, India, Lopinavir

Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …

News
abbvie_0

UK High Court rules against AbbVie’s Humira patents

March 6, 2017
Sales and Marketing AbbVie, Biogen, Fujifilm Kyowa Kirin Biologics, Humira, Samsung Bioepis, biosimilar

The UK High Court has ruled that two of AbbVie patents, related to dosing regimens for rheumatoid arthritis, psoriasis and …

News
janssen_latest_logo_on_sign_closer

Phase 3 data for Janssen psoriasis drug shows efficacy over Humira

March 6, 2017
Research and Development, Sales and Marketing Humira, Janssen, guselkumab, psoriasis

Janssen has revealed new Phase 3 data for its human monoclonal antibody guselkumab in the treatment of adults with moderate …

News
otsuka_holdings_logo

Otsuka to acquire Neurovance in potential $250 million deal

March 6, 2017
Sales and Marketing ADHD, Neurovance, Otsuka Pharmaceuticals

Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal …

News

Bioverativ adds new member to board of directors

March 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …

Appointment
genes

Gene therapy: Advanced treatments for a new era

March 3, 2017
Medical Communications gene therapy

Aranca discusses the considerable advances that have occured in the last few years in gene therapy.Considerable research has been conducted …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …

News
eu_and_fda

EU-US reach landmark deal on mutual recognition of manufacturing inspection

March 3, 2017
Medical Communications EMA, EU, FDA, US

The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …

News

Price cuts bring 14 Cancer Drugs Fund treatments into routine NHS use

March 3, 2017
Medical Communications, Sales and Marketing CDF, NICE

NICE has revealed that it has reached the halfway point in its review of the old Cancer Drugs Fund (CDF) …

News
The Gateway to Local Adoption Series

Latest content

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026